Skip to main content
Print Save

Actemra Prices, Coupons and Patient Assistance Programs

Actemra (tocilizumab) is a member of the interleukin inhibitors drug class and is commonly used for COVID-19, Cytokine Release Syndrome, Giant Cell Arteritis, and others.

Actemra prices

The cost for Actemra intravenous solution (20 mg/mL) is around $527 for a supply of 4 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

This Actemra price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Intravenous Solution

Subcutaneous Solution

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Actemra Coupons and Rebates

Actemra offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Actemra Co-pay Card Program: Eligible commercially insured patients may pay $5 per prescrition with savings of up to $15,000 calendar year; for additional information contact the program at 855-722-6729.

Applies to:
Actemra
Number of uses:
Per prescription per calendar year

Form more information phone: 855-722-6729 or Visit website

Patient Assistance Programs for Actemra

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Actemra (tocilizumab) Injection

More information please phone: 866-316-7263 Visit Website

Provider: Genentech Patient Foundation

Elligibility requirements:
  1. Uninsured or Underinsured with no prescription coverage for needed medication
  2. Based on FPL
  3. Medically appropriate condition/diagnosis
  4. Must be treated by US licensed healthcare provider
  5. The Genentech Access to Care Foundation is now the Genentech Patient Foundation. Eligibility determined on a case-by-case basis. Call for most recent medications as the list is subject to change.
Applicable drugs:
  • Actemra (tocilizumab) Injection

More information please phone: 888-941-3331 Visit Website

Provider: Genentech Access Solutions (Actemra & Rituxan)

Elligibility requirements:
  1. Determined case by case
  2. Based on FPL
  3. Varies
  4. Must be treated by US licensed healthcare provider
  5. Eligibility determined on a case-by-case basis. Contact program for details.
Applicable drugs:
  • Actemra (tocilizumab) Injection

More information please phone: 866-681-3261   or 866-422-2377   Visit Website